Paper38839628
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.
Jin S and 5 others. Inflamm Res, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review. Papers, record 38839628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38839628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vitiligo | Major topic |
| Humans | |
| Animals | |
| Autoantigens | |
| Receptors, Chemokine | |
| Signal Transduction | |
| Drug Discovery |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. LY21H110001 | Zhejiang Provincial Natural Science Foundation of China | PubMed | ||
| No. 2021KY903 | Zhejiang medical and health science and technology project | PubMed | ||
| No. [2021]21-3 | Hangzhou medical key discipline construction project | PubMed |
Source PubMed
References217
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32425260 | Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. | Semin Arthritis Rheum | 2020 | https://conductscience.org/library/papers/32425260 | PubMed |
| 2 | 19303254 | MicroRNA in autoimmunity and autoimmune diseases. | J Autoimmun | 2009 | https://conductscience.org/library/papers/19303254 | PubMed |
| 3 | 25977193 | Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance. | Discov Med | 2015 | https://conductscience.org/library/papers/25977193 | PubMed |
| 4 | 27186967 | Interleukin 10 protects primary melanocyte by activation of Stat-3 and PI3K/Akt/NF-κB signaling pathways. | Cytokine | 2016 | https://conductscience.org/library/papers/27186967 | PubMed |
| 5 | 24935676 | Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. | Pigment Cell Melanoma Res | 2014 | https://conductscience.org/library/papers/24935676 | PubMed |
| 6 | 27862977 | Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia. | Cytometry B Clin Cytom | 2018 | https://conductscience.org/library/papers/27862977 | PubMed |
| 7 | 19242513 | Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. | J Invest Dermatol | 2009 | https://conductscience.org/library/papers/19242513 | PubMed |
| 8 | 11511311 | Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. | J Invest Dermatol | 2001 | https://conductscience.org/library/papers/11511311 | PubMed |
| 9 | 24058794 | Interleukin-2 and STAT5 in regulatory T cell development and function. | JAKSTAT | 2013 | https://conductscience.org/library/papers/24058794 | PubMed |
| 10 | 20952687 | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. | Blood | 2011 | https://conductscience.org/library/papers/20952687 | PubMed |
| 11 | 33284575 | Steroid-Peptide Immunoconjugates for Attenuating T Cell Responses in an Experimental Autoimmune Encephalomyelitis Murine Model of Multiple Sclerosis. | Bioconjug Chem | 2020 | https://conductscience.org/library/papers/33284575 | PubMed |
| 12 | 22566933 | Molecular mechanisms of treg-mediated T cell suppression. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566933 | PubMed |
| 13 | 23498308 | Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India. | J Am Acad Dermatol | 2013 | https://conductscience.org/library/papers/23498308 | PubMed |
| 14 | 20175879 | Reduced skin homing by functional Treg in vitiligo. | Pigment Cell Melanoma Res | 2010 | https://conductscience.org/library/papers/20175879 | PubMed |
| 15 | 27192518 | Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review. | An Bras Dermatol | 2016 | https://conductscience.org/library/papers/27192518 | PubMed |
| 16 | 18509048 | T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18509048 | PubMed |
| 17 | 37312906 | Evaluation of polymorphisms and expression of PTPN22, NLRP1 and TYR genes in vitiligo patients. | Postepy Dermatol Alergol | 2023 | https://conductscience.org/library/papers/37312906 | PubMed |
| 18 | 18725526 | Dicer-dependent microRNA pathway safeguards regulatory T cell function. | J Exp Med | 2008 | https://conductscience.org/library/papers/18725526 | PubMed |
| 19 | 36183915 | Preclinical evaluation of a microparticle-based transdermal vaccine patch against metastatic breast cancer. | Int J Pharm | 2022 | https://conductscience.org/library/papers/36183915 | PubMed |
| 20 | 35008594 | COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008594 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42823602 | Rezpegaldesleukin and Regulatory T Cell Restoration in Immune-Mediated Skin Diseases. | Dermatol Ther (Heidelb) | 2026 | https://conductscience.org/library/papers/42823602 | PubMed |
| 42633438 | From Mechanisms to Clinical Practice: Advances in Vitiligo Treatment Across Western Medicine and Traditional Chinese Medicine. | Clin Cosmet Investig Dermatol | 2026 | https://conductscience.org/library/papers/42633438 | PubMed |
| 42233009 | Regulatory T cells in vitiligo: a review of functional disequilibrium between peripheral blood and lesional tissue. | Front Immunol | 2026 | https://conductscience.org/library/papers/42233009 | PubMed |
| 42183190 | Regulatory T cell therapy in autoimmune and immune-mediated diseases: from basic research to clinical practice and future perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183190 | PubMed |
| 41035845 | recent advances in the pathogenesis of vitiligo and the application of novel drug delivery systems in its treatment. | Int J Pharm X | 2025 | https://conductscience.org/library/papers/41035845 | PubMed |
| 40703229 | Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40703229 | PubMed |
| 40114929 | The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40114929 | PubMed |
| 39967732 | Identification of disease-specific gut microbial markers in vitiligo. | Front Microbiol | 2025 | https://conductscience.org/library/papers/39967732 | PubMed |
| 39125670 | Exploring New Frontiers: Innovations and Therapeutic Targets in Dermatology. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125670 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38839628
GET https://conductscience.org/api/papers/v1/38839628/references?page=2